For Doers

Why You

Researchers and entrepreneurs build at the frontier. Studies on pollutants sit on a goldmine of translational biology that biotech hasn't tapped. We want your help to change that.

Why Now

The biotech infrastructure has already shown to be transferable to studying pollutants. Foundation models are generalizing to a point where pharma and toxicology could converge on new insights. Chronic diseases are on the rise and we need a new playbook.